Nanjing Jingao Biomidical Technology Co. Ltd.

This early-stage study is testing a new oral tablet called WJ22096 in patients with advanced solid tumors, like lung, colorectal, and pancreatic cancer, who have no other standard treatment options. The main goals are to find a safe dose, see how the body processes the drug, and …